Clin Mol Hepatol April 2023 PMID 36710607

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective.

Tung-Hung Su, Chih-Horng Wu, Tsung-Hao Liu, Cheng-Maw Ho, Chun-Jen Liu

Mentions

12
Peak: 6 in May 2023
across 3 sources since May 2023

Extended reach

22,303
potential audience

Total likes

131

Video views

8,420

Mentions per month

May 2023 – Jun 2025

Where it's discussed

  • X / Twitter6 posts
  • News4 articles
  • YouTube2 videos

AI synopsis

What people are saying

Participants demonstrate moderate agreement and engagement by discussing the nuances of regional guidelines for HCC, particularly emphasizing Taiwan's unique management strategies, as seen in comments referencing the 'Taiwan perspective' and comparing it to other regions like Japan and China. The tone combines professional analysis with a recognition of regional differences, reflecting a balanced view of the publication’s relevance.

AgreementModerate agreement

Most comments align positively with the publication, highlighting the importance of these regional perspectives and acknowledging the value of tailored guidelines.

InterestModerate interest

The discussions reflect moderate interest, with participants expressing curiosity about regional differences in managing HCC and noting the relevance to Taiwan’s healthcare context.

EngagementModerate engagement

Posts include specific references to guidelines and case management, indicating a thoughtful level of engagement and analysis.

ImpactModerate impact

The discussions suggest that the publication influences clinical perspectives and may inform local practice improvements, but the overall impact is seen as moderate given the focus on regional nuances.

Abstract in brief

  • Hepatocellular carcinoma (HCC) is a major health issue in Taiwan, being the fourth most common cancer and a leading cause of cancer-related death, with management guided by national guidelines and policies.
  • Surveillance for HCC involves regular abdominal ultrasounds and blood tests, with advanced imaging like CT or MRI recommended for high-risk or difficult cases; diagnosis usually relies on dynamic imaging and sometimes pathology.
  • Treatment strategies include curative options like surgery and locoregional therapies for certain patients, with systemic therapies such as sorafenib or lenvatinib being reimbursed, and emerging approaches like early switching to systemic therapy for TACE-refractory cases reflecting recent shifts in management.

Top posts

Most liked on X and Bluesky
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g

May 5, 2023 · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2

May 5, 2023 · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40

May 5, 2023 · 1 share · 2,312 followers View post →

All mentions

김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g

May 5, 2023 · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2

May 5, 2023 · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

RT @DrJHK: Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40

May 5, 2023 · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective https://t.co/47QTXJ0V40

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Taiwan perspective https://t.co/1jlmb6FIe2

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →
김정한 Jeong Han Kim
@DrJHK · X

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Chinese perspective https://t.co/6z2UEjbM7g

May 4, 2023 · 1 like · 1 share · 2,312 followers View post →